期刊文献+

长期服用保列治对前列腺增生患者静态尿道压力影响的研究 被引量:3

Study of influence of long-term treatment of finasteride on quiet state urethral pressure in patients with benign prostatic hyperplasia
下载PDF
导出
摘要 目的:探讨长期服用保列治对前列腺增生患者尿道压的影响。方法:前列腺增生患者48例分成2组,各24例,实验组给予口服保列治+特拉唑嗪治疗,对照组给予安慰剂+特拉唑嗪治疗,治疗时间为3年,治疗前、服用保列治治疗1年、3年后行超声及尿流动力学检查,比较治疗前后患者前列腺体积、功能性尿道长度、最大尿道压、最大尿道闭合压变化情况。结果:在服用药物治疗3年后,实验组患者前列腺体积较对照组明显缩小(P<0.05),实验组患者最大尿道压和最大尿道闭合压力较对照组也明显降低(P<0.05)。结论:长期服用保列治可以缩小前列腺体积,降低增生前列腺组织对尿道的静态压力,从而改善尿路梗阻症状。 Objective: To explore the long - term efficacy of finasteride on quiet state urethral pressure in patients with benign prostatic hyperplasia(BPH). Methods: Forty - eight patients with BPH in our hospital were randomly assigned to the following groups( n = 24) : ( 1 ) Finastefide group : Patients were treated with finasteride plus terazosin daily for 3 years. ( 2 ) Control group : Patients were treated with placebo plus terazosin daily for 3 years. Before and after the treatment for 1,3 years, the prostate volume, functional urethral length, maximal urethral pressure and maximal urethral closure pressure were evaluated. Results: After treatment with finastcride for 3 years, the prostate volume, maximal urethral pressure and maximal urethral closure pressure of patients decreased significantly compared with control group (P 〈 0.05 ). Conclusion:Long - term administration of finasteride in patients with BPH may reduce prostate volume and quiet state urethral pressure. Therefore, it can improve urinary obstruction symptom.
出处 《西南国防医药》 CAS 2009年第10期978-980,共3页 Medical Journal of National Defending Forces in Southwest China
关键词 保列治 前列腺增生 尿动力学 特拉唑嗪 finasteride prostatic hyperplasia urodynamies terazosin
  • 相关文献

参考文献8

二级参考文献11

  • 1马腾骧主编.现代泌尿外科学[M].天津:天津科学技术出版社,2000.837.
  • 2Schaefer W, Abrams P, Liao LM, et al. Good urodynamic practices (GUP): Uroflowmetry, filling cystometry, and pressure-flow studies[J]. Neurourol Urody, 2002, 21: 261-274.
  • 3Liao LM, Krischner-Hermanns R, Schaefer W. Urodynamic quality control: Quantitative plausibility control with typical value ranges[J]. Neurourol Urody, 1999, 18: 365-366.
  • 4Schaefer W, Liao LM, Krischner-Hermanns R, et al. Urodynamic quality control: Qualitative plausibility control with typical signal patterns[J]. Neurourol Urody, 1999, 18: 366-367.
  • 5Yamamoto T, Sakskibara R, Uchiyama T,et al. Neurological diseases that cause detrusor hyperactivity with impaired contractile function[J]. Neurourol Urodyn, 2006,25(4) :356-360.
  • 6Griffiths DJ, McCracken PN, Harrison GM, et al. Urge incontinence and impaired detrusor contractility in the elderly[J]. Neurourol Urodyn, 2002,21(2):126-131.
  • 7Resnick NM, Yalla SV. Detrusor hyperactivity with impaired contractile function. An unrecognized but common cause of incontinence in elderly patients[J]. J Urol, 1987,22 (12):257.
  • 8Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction, Ⅱ. Aging detrusor:norrnal versus impaired contractility[J]. J Urol, 1993,150(5pt2):1657- 1667.
  • 9Chancellor MB, Blaivas JG, Kaplan SA, et al. Bladder outlet obstruction versus impaired detrusor contractility: the role of outflow[J].J Urol,1991,145(4):810-812.
  • 10郭骏,肖传国,曾甫清.前列腺增生症膀胱出口梗阻类型对剩余尿量的影响[J].临床泌尿外科杂志,2001,16(7):291-293. 被引量:3

共引文献237

同被引文献21

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部